✦ LIBER ✦

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

✍ Scribed by Sharon A. Spencer; Jonathan Harris; Richard H. Wheeler; Mitchell Machtay; Christopher Schultz; William Spanos; Marvin Rotman; Ruby Meredith; Kie-Kian Ang

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 132 KB
Volume: 30
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.20697

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly paclitaxel, cisplatin, tegafur,

Biweekly paclitaxel, cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy for unresectable squamous cell carcinoma of the head and neck

✍ Hung-Ming Wang; Chun-Ta Liao; Tung-Chieh Joseph Chang; Jen-Shi Chen; Cuang-Chi L 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract ## BACKGROUND The goal of the current study was to evaluate the efficacy and toxicity of paclitaxel, cisplatin (P), tegafur (T), and leucovorin (L) as a neoadjuvant chemotherapy (CT) for patients with advanced, unresectable squamous cell carcinoma of the head and neck. ## METHODS Fro

Cisplatin and 5-fluorouracil chemotherap

Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

✍ Richard J. Mercier; G. David Neal; Douglas E. Mattox; George A. Gates; Thomas C. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

A phase II trial of cisplatin and vinore

A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Enrique Espinosa; Pilar Zamora; Alfredo Millá; Serafin Morales; Raquel Molina; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv

Postoperative radiation therapy for prim

Postoperative radiation therapy for primary vs. recurrent squamous cell carcinoma of the head and neck: Results of a comparative analysis

✍ William F. Regine; Joseph Valentino; David A. Sloan; Pushpa Patel; Melissa Q. Pi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Background. There is little literature comparatively evaluating the results of postoperative radiation therapy (RT) for patients with squamous cell carcinoma (SCC) of the head and neck treated for primary versus recurrent disease. Methods. Between 1981 and 1993, 174 patients with SCC of the head an

Pilot trial of concomitant chemotherapy

Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck

✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; João V. Salvajoli; Andrew J. Si 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

A randomized trial of cisplatin (CACP) +

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

✍ Julie A. Kish; John F. Ensley; John Jacobs; Arthur Weaver; Glenn Cummings; Muhyi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views